Evaluation of Stepping Stones
The Policy & Research Group · with Department of Health and Human Services, Mathematica Policy Research, Inc. · NCT06574217
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 12–22 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 650
- US sites recruiting
- 1
- Study start
- September 16, 2024
- Record last updated
- May 13, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this randomized trial is to learn if the Stepping Stones (StSt) intervention has a positive impact on the sexual health and relationship behaviors of sexually active youth between the ages of 12 and 22 years old who are at risk for or involved in the legal or child welfare systems. The primary research questions it aims to answer are:
- Three months after being offered the intervention, does StSt impact youth's receipt of sexually transmitted infection testing in the past four months?
- Nine months after being offered the intervention, does StSt impact youth's frequency of having vaginal and anal sex without condoms in the past four months?
- Nine months after being offered the intervention, does StSt impact youth's perpetration of emotional abuse in the past four months?
Researchers will compare participants randomized to receive StSt (treatment group) to participants randomized to receive a control condition that contains no sexual or reproductive health information (control group).
Participants randomized to the treatment group will be offered StSt as an in-person or virtual, individual-based intervention delivered over four sessions during a 6-8 week period. Participants randomized to the control group will be offered a virtually delivered control condition.
Being studied: Stepping Stones (StSt); Like
Conditions: Teen Pregnancy Prevention
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- At risk for or involved in the legal or child welfare systems
- Report ever having vaginal and/or anal sex and plan to have sex in the next six months
- Comfortable reading, speaking, and writing in English
Exclusion Criteria
- Currently trying to start a pregnancy
- Currently in jail or being detained in a facility
- Enrolled in an ongoing PRG-run TPP study, the No Baby No study, or the Yes \& Know study
- Living in regions where the FLASH curriculum is widely implemented (King County, WA, Ramsey County, MN, Hennepin County, MN)
- Identified as fraudulent (only for individuals recruited online)
Recruiting US locations
The Policy & Research Group
New Orleans, LA 70118
Site contact: Hilary Demby, MPH · 504-865-1545 · hilary@policyandresearch.com
Study contacts (from the official record)
- Hilary Demby, MPH · 504-865-545 · hilary@policyandresearch.com
- Kelly Burgess, MPH · 504-865-545 · kelly@policyandresearch.com
Similar studies in Louisiana
All pregnancy studies in Louisiana →- RecruitingHealthy volunteersPhase 3
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
Pfizer
- Location
- New Orleans, LA + 76 other US sites
- Eligibility basics
- Ages 0 mo+
- RecruitingHealthy volunteersPhase 3
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Pfizer
- Location
- Covington, LA + 111 other US sites
- Eligibility basics
- Ages 0 mo–49
- RecruitingHealthy volunteers
Non-Invasive Preeclampsia Screening and Biobank
Sequenom, Inc.
- Location
- Metairie, LA + 15 other US sites
- Eligibility basics
- Ages 18+ · Women only
- RecruitingPhase 3
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
Ascendis Pharma A/S
- Location
- New Orleans, LA + 21 other US sites
- Eligibility basics
- Ages 2–17